Jeremias A - Search Results

1

The impact of revascularization on mortality in patients with nonacute coronary artery disease.

Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. Jeremias A, et al. Am J Med. 2009 Feb;122(2):152-61. doi: 10.1016/j.amjmed.2008.07.027. Am J Med. 2009. PMID: 19185092

2

Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention.

Jeremias A, Kirtane A. Jeremias A, et al. Ann Intern Med. 2008 Feb 5;148(3):234-8. doi: 10.7326/0003-4819-148-3-200802050-00199. Epub 2007 Dec 17. Ann Intern Med. 2008. PMID: 18087049 Free article. Review.

3

Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'.

Jeremias A, Ruisi CP, Kirtane AJ, Lee T, Sylvia B, Pinto DS, Ho KK, Cutlip DE, Carrozza JP Jr, Cohen DJ. Jeremias A, et al. Coron Artery Dis. 2008 Mar;19(2):111-5. doi: 10.1097/MCA.0b013e3282f34220. Coron Artery Dis. 2008. PMID: 18300748

4

Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.

Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ; Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators. Jeremias A, et al. Circulation. 2008 Aug 5;118(6):632-8. doi: 10.1161/CIRCULATIONAHA.107.752428. Epub 2008 Jul 21. Circulation. 2008. PMID: 18645057

5

Provisional use of glycoprotein IIb/IIIa inhibitors in the era of dual antiplatelet therapy--do "bailouts" pay off?

Jeremias A, Gruberg L. Jeremias A, et al. J Invasive Cardiol. 2009 Jun;21(6):264-5. J Invasive Cardiol. 2009. PMID: 19494401 No abstract available.

6

A mechanical approach to limit contrast-induced nephropathy: sentinel at the gate.

Gruberg L, Jeremias A. Gruberg L, et al. Among authors: jeremias a. J Invasive Cardiol. 2009 Jul;21(7):319-20. J Invasive Cardiol. 2009. PMID: 19571340 No abstract available.

7

Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting.

Jeremias A, Vasu S, Gruberg L, Kastrati A, Stone GW, Brown DL. Jeremias A, et al. Catheter Cardiovasc Interv. 2010 May 1;75(6):895-902. doi: 10.1002/ccd.22349. Catheter Cardiovasc Interv. 2010. PMID: 20088008

8

Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction.

Jeremias A, Gruberg L, Patel J, Connors G, Brown DL. Jeremias A, et al. Am J Cardiol. 2010 May 1;105(9):1268-71. doi: 10.1016/j.amjcard.2009.12.043. Epub 2010 Mar 11. Am J Cardiol. 2010. PMID: 20403477

9

Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L. Parikh PB, et al. Among authors: jeremias a. Am J Cardiol. 2011 May 1;107(9):1319-23. doi: 10.1016/j.amjcard.2010.12.042. Epub 2011 Feb 23. Am J Cardiol. 2011. PMID: 21349486

10

Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease.

Bench TJ, Jeremias A, Brown DL. Bench TJ, et al. Among authors: jeremias a. Pharmacol Res. 2011 Dec;64(6):561-6. doi: 10.1016/j.phrs.2011.05.002. Epub 2011 May 11. Pharmacol Res. 2011. PMID: 21624471 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page